Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... and low dose total body irradiation in patients undergoing allogeneic stem cell transplantation. A study population of 80 subjects will be enrolled ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  2. Intra-Osseous Co-Transplant of UCB and hMSC

    ... the patient's immune system from rejecting the donor's stem cells . The donated stem cells may replace the patient's immune cells ... or chloroma) Recipients of prior autologous or allogeneic transplant are eligible, as long as at least 3 months have passed ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  3. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    ... successfully treated with immunosuppressive drug regimens or allogeneic stem cell transplantation. However, 20-40% of patients are ineligible for ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  4. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... (such as renal transplant) are excluded Patients with allogeneic stem cell transplantation within the last 6 months and patients with active ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  5. Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

    ... one of two study arms; Arm 1: Reduced intensity conditioning allogeneic hematopoietic cell transplantation (RIC-alloHCT), Arm 2: ... Cell Transplant Bone marrow or peripheral blood stem cell transplant. The specific transplant treatment regimen will be at the ...

    Clinical Trial last updated 04/28/2016 - 10:50am.

  6. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... conditions for which CD34+ selected, T-cell depleted allogeneic hematopoietic stem cell transplantation is indicated such as: AML in 1st remission - ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  7. Allo HSCT Using RIC for Hematological Diseases

    ... regimen followed by a related or unrelated donor stem cell infusion. The primary objective is to evaluate rates of acute ... Blood Stem Cells On day 0, patients will receive an allogeneic transplant using PBSC which are CD34+ selected as the donor graft. ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  8. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... and disease free survival of 85% to 100%, can be obtained in allogeneic blood or bone marrow stem cell transplantation using an human leukocyte antigen ( HLA ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  9. Transplantation Update

    ... toxicity from the regimens used to prepare patients for stem cell transplants regardless of who the donor is or the source of stem ... add that even patients who are 70 may be doing well with an allogeneic transplant but if they develop problems, like GVHD and they are then ...

    Interview last updated 05/14/2015 - 2:42pm.

  10. Nurse's Corner Summer 2015: Understanding the Etiology and Epidemiology of Myelodysplastic Syndromes

    ... Syndromes (MDS) are a group of malignant hematopoietic stem cell diseases characterized by bone marrow failure , with resultant ... higher risk, the goal of treatment is to improve survival. Allogeneic hematopoietic stem cell transplant and hypomethyalting ...

    Page last updated 07/27/2015 - 12:04pm.